GTPase KRas (7-15)

GTPase KRas (7-15) is a synthetic peptide fragment corresponding to amino acid residues 7 through 15 of the KRas protein, a pivotal member of the Ras family of small GTPases. This peptide sequence plays a crucial role in the structural and functional analysis of KRas, which is integral to signal transduction pathways regulating cell growth, differentiation, and survival. Researchers use such defined peptide segments to dissect the molecular mechanisms of protein-protein interactions, post-translational modifications, and conformational dynamics within the Ras superfamily. As a research tool, the 7-15 segment of KRas provides a focused means to study specific motifs and binding domains relevant to the protein's regulatory functions in cellular signaling networks.

Peptide mapping: In proteomic studies, the KRas (7-15) peptide is employed as a reference standard for peptide mapping and mass spectrometry-based analyses. Its well-defined sequence allows researchers to validate enzymatic digestion protocols and optimize analytical workflows for the identification and quantification of KRas-derived peptides in complex biological samples. By serving as a benchmark, this peptide fragment facilitates the accurate characterization of KRas isoforms and post-translational modifications, which are critical for understanding the regulation and dysregulation of Ras-mediated pathways in various cellular contexts.

Epitope mapping: The defined sequence of this peptide makes it a valuable tool for epitope mapping experiments aimed at identifying antibody binding sites within the KRas protein. By using the 7-15 segment in immunoassays, scientists can determine the specificity and affinity of monoclonal or polyclonal antibodies targeting KRas. Such studies are essential for the development and validation of research-grade antibodies, which are widely utilized in Western blotting, immunoprecipitation, and immunohistochemistry applications. The ability to pinpoint antibody epitopes enhances the reliability and interpretability of immunological assays involving KRas.

Protein interaction studies: As a representative motif from the KRas protein, the 7-15 peptide is frequently used in in vitro binding assays to explore protein-protein or protein-ligand interactions. Researchers can immobilize or label the peptide to investigate its binding partners, such as effector proteins, regulatory molecules, or synthetic ligands. These studies shed light on the structural determinants of KRas function and contribute to the delineation of signaling cascades mediated by Ras family proteins. The peptide format offers a controlled system to dissect interaction interfaces without the complexity of full-length proteins.

Peptide synthesis validation: The KRas (7-15) sequence is also employed as a model system for optimizing solid-phase peptide synthesis protocols. Its moderate length and well-characterized sequence make it suitable for testing coupling efficiencies, protecting group strategies, and purification methods. By monitoring the synthesis and analytical performance of this peptide, chemists can refine their methodologies for producing high-quality synthetic peptides, which are essential reagents in biochemical and pharmaceutical research.

Structural and conformational analysis: The 7-15 fragment of KRas serves as a subject for structural studies using techniques such as nuclear magnetic resonance (NMR) spectroscopy or circular dichroism (CD) analysis. These investigations provide insights into the local secondary structure propensity and conformational flexibility of the peptide, which may influence its interactions with other biomolecules. By studying isolated segments, researchers can better understand how specific regions contribute to the overall folding, stability, and function of the full-length KRas protein, thereby advancing the broader field of Ras biology.

1. Glucagonlike peptide 2 analogue teduglutide: stimulation of proliferation but reduction of differentiation in human Caco-2 intestinal epithelial cells

2. Multifunctional peptide-oligonucleotide conjugate promoted sensitive electrochemical biosensing of cardiac troponin I

3. Investigating Potential Interactions Between Neurohypophyseal Peptides, their Drug Analogs, and Coagulation Factor VIII

4. Characterization of Novel P-Selectin Targeted Complement Inhibitors in Murine Models of Hindlimb Injury and Transplantation

5. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment